Skip to main content

Day: June 4, 2025

Cornish Metals Provides an Update for the South Crofty Tin Project

Orders Placed for Key Long Lead Items TMG Engaged to Provide Project Management Services VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to provide a project update. The Company has placed long lead item orders for two winders and has engaged Technical Management Group Ltd (“TMG”) to provide project management consulting services for the development of South Crofty. Winder Orders Orders have been placed with Qualter Hall & Company Limited (“Qualter Hall”) for the design, manufacture, supply, installation and commissioning of the production and service winders to be...

Continue reading

Performance Shipping Inc. Announces Fixed Income Investor Meetings

ATHENS, Greece, June 04, 2025 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“Performance Shipping” or the “Company”), through its Norwegian investment banks, will arrange a series of fixed income investor calls commencing on June 6, 2025. A five-year USD denominated senior unsecured bond issue may follow, subject to inter alia market conditions. The net proceeds from the contemplated bond issue shall be applied towards fleet expansion and renewal and general corporate purposes of the Company. The senior unsecured bonds, if issued, will be offered in the United States or its territories only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “U.S. Securities Act”), and sold outside the United States only to non-U.S. persons...

Continue reading

Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers the same efficacy and safety demonstrated in available oral solution Evrysdi is the only non-invasive disease-modifying SMA treatment, with more than 18,000 people with SMA treated globally to dateBasel, 04 June 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved a label extension for Evrysdi® (risdiplam) to include a new, room-temperature stable tablet for people living with spinal muscular atrophy (SMA). The 5mg tablet (approx. 6.5mm), which can either be swallowed whole or dispersed in water, can be taken with or without food and does not require refrigeration, when stored at room temperature. Administered at home, Evrysdi is the...

Continue reading

Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update

Saint-Herblain (France), June 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced the availability of documentation for its Combined General Meeting (“the Meeting”) to be held on June 25, 2025 at 2:00 p.m. CEST at the Sofitel Lyon Bellecour Hotel, 20 quai du Docteur Gailleton, 69002 Lyon (France). The Preliminary Notice of Meeting – including the agenda, the draft resolutions proposed by the Board of Directors, and instructions for participation and voting to the Meeting – was published in the Bulletin des Annonces Légales Obligatoires (BALO) on May 21, 2025. The information and preparatory documents related to this Meeting are available on Valneva’s website via this Link. Any shareholder wishing to receive, by mail or e-mail, Meeting documents referred to in Article...

Continue reading

WISeKey International Holding Ltd Announces Adjournment of 2025 Annual General Meeting

WISeKey International Holding Ltd Announces Adjournment of 2025 Annual General Meeting Zug, Switzerland, June 4, 2025 – Ad-Hoc announcement pursuant to Art. 53 of SIX Listing Rules – WISeKey International Holding Ltd. (“WISeKey” or the “Company”) (SIX: WIHN, NASDAQ: WKEY), leading global cybersecurity, blockchain, and IoT company, announced today that the Board of Directors has decided, for logistical reasons, to ajourn the 2025 Annual General Meeting of Shareholders (“AGM“) from June 19, 2025, 2:00 p.m. Swiss time, to June 27, 2025, at 2:00 p.m. Swiss time. The venue of the 2025 AGM will remain the offices of Homburger AG, Prime Tower, Hardstrasse 201, 8005 Zurich, Switzerland. Admittance to the 2025 AGM will start at 1:30 p.m. Swiss time. Other than the date of the AGM, nothing will change. In particular, the items on the agenda of...

Continue reading

World’s Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care

New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium, 4 June 2025 – IBA (Ion Beam Applications SA), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the launch of Proton Therapy Academy, a new global training and education initiative developed in partnership with prominent institutions in the field of proton therapy. The Academy has been unveiled at the 2025 PTCOG (Particle Therapy Co-Operative Group) annual conference, currently taking place in Buenos Aires, Argentina. Visit www.protontherapy-academy.com for more information. As global demand for proton therapy grows, so does the need for multifaceted training. With many new centers emerging worldwide, The Proton Therapy Academy...

Continue reading

SIKA TO ADVANCE THE DIGITAL TRANSFORMATION OF THE CONSTRUCTION INDUSTRY WITH GIATEC

SIKA TO ADVANCE THE DIGITAL TRANSFORMATION OF THE CONSTRUCTION INDUSTRY WITH GIATEC Sika has made a strategic investment in Giatec™ Scientific Inc., a global leader in digital concrete technology platforms specializing in smart testing and AI-driven solutions, headquartered in Canada. Giatec develops advanced sensors, software, and data analytics tools to optimize concrete quality, durability, and sustainability, from production and delivery to placement. This investment represents a significant milestone in Sika’s overall digital strategy, helping the construction industry to improve efficiency and reduce carbon footprint. One key challenge in concrete production is the tendency to overdesign concrete mixes due to raw material fluctuations. With Giatec’s AI-powered concrete mix optimization and Sika’s advanced admixture technologies,...

Continue reading

Icelandic Salmon AS – Notice of Annual General Meeting 2025

Bíldudalur, 4 June 2025 The annual general meeting of Icelandic Salmon AS (the “Company”) will be held on 18 June 2025 at 11:00 (CEST). Please find the notice including appendices enclosed. The documents are also made available on the Company’s website https://arnarlax.is/investors/. For more information, please contact: Björn Hembre, CEO. Tel: +47 913 47 432 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsAppendix 1 – Registration FormAppendix 2 – Proxy formIcelandic Salmon AS – AGM Notice 2025

Continue reading

North America high-net-worth individual population surges, while Europe and Middle East shrink

Press contact:Fahd PashaTel.: +1 647 860 3777E-mail: Fahd.Pasha@capgemini.com North America high-net-worth individual population surges, while Europe and Middle East shrinkU.S. led the world in growth in its millionaire population, adding 562,000 to reach 7.9 million Ultra-high net worth individual population rises by 6.2% worldwide High-net-worth individuals now allocate 15% of their portfolios to alternative investments, including cryptocurrenciesParis, June 4, 2025 – The Capgemini Research Institute’s World Wealth Report 2025, published today, reveals the global high-net-worth individuals1 (HNWIs) population rose by 2.6% in 2024. Now in its 29th edition, the report finds this increase was driven by the growth in the population of ultra-high-net-worth individuals (UHNWIs), which grew by 6.2%, as strong stock markets and AI optimism...

Continue reading

Merus N.V. Announces Pricing of Public Offering of Common Shares

UTRECHT, The Netherlands and CAMBRIDGE, Mass., June 04, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics®), today announced the pricing of an underwritten public offering of 5,263,158 common shares, at a public offering price of $57.00 per share (the “Offer Shares”). Merus also granted the underwriters a 30-day option to purchase up to an additional 789,473 common shares (the “Option Shares” and together with the Offer Shares, the “Shares”). The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses and excluding the underwriters’ option to purchase the Option Shares, are expected...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.